194 related articles for article (PubMed ID: 18031602)
1. Intramuscular delivery of rAAV-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats.
Wang T; Hou LB; Liu ZJ; Wang Y; Chen CL; Xiao X; Wang DW
Acta Pharmacol Sin; 2007 Dec; 28(12):1898-906. PubMed ID: 18031602
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.
Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW
Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated virus-mediated human kallikrein gene therapy prevents high-salt diet-induced hypertension without effect on basal blood pressure.
Yan JT; Wang T; Li J; Xiao X; Wang DW
Acta Pharmacol Sin; 2008 Jul; 29(7):808-14. PubMed ID: 18565278
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated virus-mediated delivery of antisense angiotensin II receptor 1 gene attenuates hypertension development.
Li XG; Yan JT; Xu XZ; Wang JN; Cheng LM; Wang T; Zuo P; Wang DW
Acta Pharmacol Sin; 2007 Nov; 28(11):1737-45. PubMed ID: 17959024
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein gene therapy in newborn and adult hypertensive rats.
Chao J; Yang Z; Jin L; Lin KF; Chao L
Can J Physiol Pharmacol; 1997 Jun; 75(6):750-6. PubMed ID: 9276159
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
[TBL] [Abstract][Full Text] [Related]
7. Expression of recombinant adeno-associated virus in the brain of rats with a focal embolic stroke via carotid artery.
Han Z; Zhang S; Li H; Ruan X; Xiao X; Tao W; Wang D
Chin Med J (Engl); 2002 Aug; 115(8):1170-4. PubMed ID: 12215285
[TBL] [Abstract][Full Text] [Related]
8. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
[TBL] [Abstract][Full Text] [Related]
9. GDNF gene therapy attenuates retinal ischemic injuries in rats.
Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP
Mol Vis; 2004 Feb; 10():93-102. PubMed ID: 14961006
[TBL] [Abstract][Full Text] [Related]
10. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
[TBL] [Abstract][Full Text] [Related]
11. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.
Lau D; McGee LH; Zhou S; Rendahl KG; Manning WC; Escobedo JA; Flannery JG
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3622-33. PubMed ID: 11006261
[TBL] [Abstract][Full Text] [Related]
12. Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis.
Yan JT; Wang T; Wang DW
Acta Pharmacol Sin; 2009 Sep; 30(9):1253-61. PubMed ID: 19684610
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat.
Nomoto T; Okada T; Shimazaki K; Yoshioka T; Nonaka-Sarukawa M; Ito T; Takeuchi K; Katsura KI; Mizukami H; Kume A; Ookawara S; Ikeda U; Katayama Y; Ozawa K
Gene Ther; 2009 Mar; 16(3):383-91. PubMed ID: 18818668
[TBL] [Abstract][Full Text] [Related]
14. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.
Cheng HC; Yeh SI; Tsao YP; Kuo PC
Mol Vis; 2007 Dec; 13():2344-52. PubMed ID: 18199977
[TBL] [Abstract][Full Text] [Related]
15. Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats.
Shenouda SM; Johns C; Kintsurashvili E; Gavras I; Gavras H
Am J Hypertens; 2006 Nov; 19(11):1135-43. PubMed ID: 17070424
[TBL] [Abstract][Full Text] [Related]
16. Central delivery of human tissue kallikrein gene reduces blood pressure in hypertensive rats.
Wang C; Chao C; Madeddu P; Chao L; Chao J
Biochem Biophys Res Commun; 1998 Mar; 244(2):449-54. PubMed ID: 9514899
[TBL] [Abstract][Full Text] [Related]
17. Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys.
Rudich SM; Zhou S; Srivastava R; Escobedo JA; Perez RV; Manning WC
J Surg Res; 2000 May; 90(2):102-8. PubMed ID: 10792948
[TBL] [Abstract][Full Text] [Related]
18. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.
Pan RY; Chen SL; Xiao X; Liu DW; Peng HJ; Tsao YP
Arthritis Rheum; 2000 Feb; 43(2):289-97. PubMed ID: 10693868
[TBL] [Abstract][Full Text] [Related]
19. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
[TBL] [Abstract][Full Text] [Related]
20. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy.
Hsu PY; Yang YW
J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
